278 related articles for article (PubMed ID: 37454557)
21. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.
Vellan CJ; Jayapalan JJ; Yoong BK; Abdul-Aziz A; Mat-Junit S; Subramanian P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216204
[TBL] [Abstract][Full Text] [Related]
22. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
World J Gastroenterol; 2014 Oct; 20(38):13833-41. PubMed ID: 25320520
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
24. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma.
Li Q; Zhou Z; Chen Y; Yu J; Zhang H; Meng Y; Zhu M; Li N; Zhou J; Liu F; Fang X; Li J; Wang T; Lu J; Zhang T; Xu J; Shao C; Bian Y
Abdom Radiol (NY); 2023 Jun; 48(6):2074-2084. PubMed ID: 36964775
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis.
Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ
Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034
[TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
[TBL] [Abstract][Full Text] [Related]
27. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
[No Abstract] [Full Text] [Related]
28. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.
Laeseke PF; Chen R; Jeffrey RB; Brentnall TA; Willmann JK
Radiology; 2015 Dec; 277(3):644-61. PubMed ID: 26599925
[TBL] [Abstract][Full Text] [Related]
29. Large-scale pancreatic cancer detection via non-contrast CT and deep learning.
Cao K; Xia Y; Yao J; Han X; Lambert L; Zhang T; Tang W; Jin G; Jiang H; Fang X; Nogues I; Li X; Guo W; Wang Y; Fang W; Qiu M; Hou Y; Kovarnik T; Vocka M; Lu Y; Chen Y; Chen X; Liu Z; Zhou J; Xie C; Zhang R; Lu H; Hager GD; Yuille AL; Lu L; Shao C; Shi Y; Zhang Q; Liang T; Zhang L; Lu J
Nat Med; 2023 Dec; 29(12):3033-3043. PubMed ID: 37985692
[TBL] [Abstract][Full Text] [Related]
30. BIRC5 is a target for molecular imaging and detection of human pancreatic cancer.
Liu SH; Hong Y; Markowiak S; Sanchez R; Creeden J; Nemunaitis J; Kalinoski A; Willey J; Erhardt P; Lee J; van Dam M; Brunicardi FC
Cancer Lett; 2019 Aug; 457():10-19. PubMed ID: 31059751
[TBL] [Abstract][Full Text] [Related]
31. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
32. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
34. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe.
Tonini V; Zanni M
World J Gastroenterol; 2022 Aug; 28(31):4235-4248. PubMed ID: 36159004
[TBL] [Abstract][Full Text] [Related]
35. Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence.
Borsekofsky S; Tsuriel S; Hagege RR; Hershkovitz D
Sci Rep; 2023 Aug; 13(1):13628. PubMed ID: 37604973
[TBL] [Abstract][Full Text] [Related]
36. Artificial Intelligence to Predict Lymph Node Metastasis at CT in Pancreatic Ductal Adenocarcinoma.
Bian Y; Zheng Z; Fang X; Jiang H; Zhu M; Yu J; Zhao H; Zhang L; Yao J; Lu L; Lu J; Shao C
Radiology; 2023 Jan; 306(1):160-169. PubMed ID: 36066369
[TBL] [Abstract][Full Text] [Related]
37. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
38. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
[TBL] [Abstract][Full Text] [Related]
39. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
[TBL] [Abstract][Full Text] [Related]
40. Artificial intelligence for early detection of pancreatic adenocarcinoma: The future is promising.
Mendoza Ladd A; Diehl DL
World J Gastroenterol; 2021 Apr; 27(13):1283-1295. PubMed ID: 33833482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]